¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20
±³À°ÀÏÀÚ : 2021-02-20
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021      
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ½ÅÀåÇÐȸ»ç¹«±¹
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í 1Àϵî·Ï½Ã 50,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 20ÀÏ  09:10~09:40 Key issues in the management of electrolyte and acid-base disorders  ±è±ÙÈ£(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  09:40~10:10 Calcium metabolism in general population and kidney disease patients: an overview  ¹èÀºÈñ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  10:10~10:40 Proper use of diuretics: oldies but goodies  À¯°æµ·(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  10:50~11:20 The role of continuous renal replacement therapy in sepsis-induced AKI  Á¶ÀåÈñ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  11:20~11:50 AKI in patients with hepatic failure: hepatorenal syndrome vs. septic AKI  ÃÖÈÆ¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  11:50~12:20 Fluid and nutritional management of AKI patients: during vs. after CRRT  ÀåÇý·Ã(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  13:20~13:50 Glomerular disease: evaluation and differential diagnosis  ¹®ÁÖ¿µ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  13:50~14:20 Evidence-based clinical practice guidelines for nephrotic syndrome  ¼Û»óÇå(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  14:20~14:50 Overview of the classification and treatment of crescentic glomerulonephritis  ÁøÈ£ÁØ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  14:50~15:20 Differential diagnosis and treatment of thrombotic microangiopathies  ÃÖ´ëÀº(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  15:30~16:00 Transplant immunobiology  ÀÌÁ¾¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  16:00~16:30 Immunologic test & monitoring in kidney transplant recipients  ±è¹ü¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  16:30~17:00 Recent advances in evaluation & management for transplant rejection  Çѽ¿±(°è¸íÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  17:00~17:30 ABO-incompatible KT & HLA-incompatible KT: update  ¾çö¿ì(°¡Å縯ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦22ȸ ü°èÀû ¹®Çå °íÂû(¸ÞŸºÐ¼®)À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©샾 : 2021-02-20
´ÙÀ½±Û °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦22ȸ ü°èÀû ¹®Çå °íÂû(¸ÞŸºÐ¼®)À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©샾 : 2021-02-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
679 °­¿ø ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø Á¦ 131ȸ ¼ÒÈ­±â¼¾ÅÍ ¿¬¼ö±³À° : 2018-10-17 0 548 2018-08-29
678 ¼­¿ï ÇѾç´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö°­ÁÂ(Ÿ¾×¼±Áúȯ) : 2018-10-17 0 665 2018-08-29
677 °æ±â ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø Áö¿ªÀǾàÇ° ¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-10-17 0 988 2018-08-29
676 ´ë±¸ 2018³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-10-16 0 871 2018-08-29
675 ±¤ÁÖ Á¦1ȸ Àü³²´ëÇб³º´¿ø õ½Ä¾Ë·¹¸£±â³»°ú ¿¬¼ö°­Á : 2018-10-14 0 1,097 2018-08-29
674 ¼­¿ï ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ICO2018SEOUL : 2018-10-14 0 937 2018-08-29
673 Á¦ÁÖ 2018³â Á¦4ȸ ´ëÇѽÅÀåÇÐȸ Á¦ÁÖÁöȸ Åõ¼® ½ÉÆ÷Áö¾ö : 2018-10-14 0 965 2018-08-29
672 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 SATISFACTION 4th Symposium Program : 2018-10-14 0 1,599 2018-08-29
671 ¼­¿ï ´ëÇÑ°ñ´Ù°øÁõÇÐȸ Á¦ 42ȸ Ã߰迬¼ö°­Á : 2018-10-14 0 461 2018-08-29
670 ºÎ»ê ÇØ¿î´ë ¹éº´¿ø Á¦31Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2018-10-14 0 948 2018-08-29
669 °æ±â Á¦4Â÷ ÇÏÁöÁ¤¸Æ·ù¿¬±¸È¸ Çмú½ÉÆ÷Áö¿ò : 2018-10-14 0 1,134 2018-08-29
668 ¼­¿ï 2018 ´ëÇÑÈ­Çпä¹ýÇÐȸ Ç×»ýÁ¦ ¿Ã¹Ù·Î ¾²±â °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-14 0 658 2018-08-29
667 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦ 34ȸ ¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö°­Á – Åõ¼® Ä¡·áÀÇ ÃֽŠÁö°ß : 2018-10-14 0 1,810 2018-08-29
666 ¼­¿ï ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ICO2018SEOUL : 2018-10-13 0 750 2018-08-29
665 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö : 2018-10-13 0 1,045 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷